TMEM92 and gastric cancer: Multivariate analysis further confirmed that the expression level of TMEM92‐AS1 could be regarded as an independent risk factor for OS in GC patients (P = 0.007), along with N (P = 0.028), TNM (P < 0.001) and tumour size (P = 0.006).